Harvard University (Massachusetts General Hospital) — Boston, Massachusetts

Harvard University (Massachusetts General Hospital) is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Harvard University (Massachusetts General Hospital) has participated in 1 clinical trials.

Therapeutic areas: Spinocerebellar Ataxias, Spinocerebellar Ataxia Genotype Type 1, Spinocerebellar Ataxia Genotype Type 2.

Sponsors: Biohaven Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Harvard University (Massachusetts General Hospital)?

Harvard University (Massachusetts General Hospital) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Harvard University (Massachusetts General Hospital) conducted?

Harvard University (Massachusetts General Hospital) has 1 clinical trials on record. Their work covers Spinocerebellar Ataxias, Spinocerebellar Ataxia Genotype Type 1, Spinocerebellar Ataxia Genotype Type 2.

Is Harvard University (Massachusetts General Hospital) accredited by Crixeo Health?

Harvard University (Massachusetts General Hospital) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Harvard University (Massachusetts General Hospital)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.